If a Stadium is in play, this attack does 70 more damage.
Probopass (Destined Rivals) is presently valued at about $0.12 in raw condition. Week-over-week change is limited (0.0%), indicating short-term stability.
Against its 30-day baseline of $0.10, this card is pricing 22.9% higher. Its 90-day trading band runs between $0.03 and $0.13, producing a 83% range and high-volatility behavior.
The listed rarity for this print is Uncommon.
Market structure summary: The latest week is near flat (0.0%), suggesting consolidation rather than breakout behavior. The 90-day range spans $0.03 to $0.13 (83% spread), which indicates high-volatility behavior.
Current value is 22.9% above its 30-day reference ($0.10). Without a consistent graded comp in the current snapshot, live listings are still required for reliable condition-based valuation.
In 2025, Destined Rivals introduced this print of Probopass. Core profile: Its card type is Pokémon.
The rarity label is Uncommon. Printed HP is 140.
Energy typing is Fighting. As an evolution, Probopass develops from Nosepass.
Notable move text references "Power Gem" and "Mountain Drop". Grass weakness applies to this print.
A wider Probopass checklist helps contextualize this specific Probopass print. This comparison sample includes 6 alternatives across 5 sets.
In this sample, pricing ranges between $0.07 and $3.41 (4771% total span). Relative to the alternative average ($0.69), this card is -83%.
Notable alternatives include Probopass #95 (Primal Clash) at $0.24, Probopass #55 (Steam Siege) at $0.19, Probopass #99 (Brilliant Stars) at $0.08, and Probopass #131 (Rebel Clash) at $0.17.
Destined Rivals was released in 2025. Series classification for this set is Scarlet & Violet.
With 244 listed cards, this is a large set by modern TCG standards. As of 2026, the set is 1 year old and still in a recent release window.
Probopass (#98) is one of the Uncommon prints in this expansion.
